CRISPR Therapeutics (CRSP) Stock: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$49.27
-0.72 (-1.43%)
▼
5d:
+0.05%
30d:
-11.54%
90d:
+5.44%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $49.27, which is considered oversold relative to its 30-day fair value range of $50.46 to $56.21.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $47.36, while resistance sits at $53.21.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $85.63 (+71.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $47.36, while resistance sits at $53.21.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $85.63 (+71.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$50.46 -
$56.21
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.3% below Wall St target ($85.63)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$50.46 -
$56.21
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$47.36
Resistance Level
$53.21
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.07
Wall Street Target
$85.63
(+71.3%)
Revenue Growth (YoY)
1041.4%
Share & Embed Analysis
Last updated: October 23, 2026 2:54 PM ET
Data refreshes hourly during market hours. Next update: 3:54 PM
Data refreshes hourly during market hours. Next update: 3:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
